To evaulate and compare the financial burden of various surgical interventions for the management of benign prostatic hyperplasia (BPH).
We identified commercially insured men with a diagnosis of BPH who underwent a procedure of interest (SP, TURP, HoLEP, PVP, PUL, or WVTT) between 2015-2021 with the OptumLabs Data Warehouse.